Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
Crossref DOI link: https://doi.org/10.1007/s10067-015-2861-x
Published Online: 2015-01-22
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Witte, Torsten
License valid from 2015-01-22